DashboardPortfoliosWatchlistCommunityDiscoverScreener
  • Community
  • /
  • Switzerland
  • /
  • Healthcare
Author Program NEWCreate Narrative
AEVS logo

Aevis Victoria SA Stock Price

SWX:AEVS Community·CHF 1.3b Market Cap
  • 1 Narratives written by author
  • 0 Comments on narratives written by author
  • 2 Fair Values set on narratives written by author
Author Program NEWCreate Narrative

AEVS Share Price Performance

CHF 0
-13.60 (-100.00%)
​
CHF 17.00
Fair Value
CHF 0
-13.60 (-100.00%)
​
Price CHF 0
Wed, 13 May 26
Fair ValueCHF 17.00
Share Pricen/a

AEVS Community Narratives

AN
AnalystConsensusTarget
AnalystConsensusTarget's
Fair Value
·
Fair Value CHF 17 12.9% undervalued intrinsic discount

Aging Population And Integrated Care Model Will Support Future Hospital And Real Estate Earnings

0users have liked this narrative
0users have commented on this narrative
1users have followed this narrative
AEVS logo
Aevis Victoria
12.9% undervalued intrinsic discount

Aging Population And Integrated Care Model Will Support Future Hospital And Real Estate Earnings

View narrative
AN
AnalystConsensusTarget
AnalystConsensusTarget
Published 13 May
Read Narrative

Trending Discussion

No trending discussion available.

Recently Updated Narratives

AN
AnalystConsensusTarget
AEVS logo

Aging Population And Integrated Care Model Will Support Future Hospital And Real Estate Earnings

Fair Value: CHF 17 12.9% undervalued intrinsic discount
1 fair value setusers have set this as their fair value
0 commentsusers have commented on this narrative
0 likesusers have liked this narrative

Snowflake Analysis

Moderate growth potential with very low risk.

2 Risks
1 Reward
View Full Analysis

Aevis Victoria SA Key Details

CHF 0

Revenue

CHF 0

Cost of Revenue

CHF 0

Gross Profit

CHF 0

Other Expenses

CHF 0

Earnings

Last Reported Earnings
Jun 30, 2026
Next Reporting Earnings
Apr 08, 2027
-0.24
24.99%
-1.93%
164.4%
View Full Analysis

About AEVS

Founded
2006
Employees
4870
CEO
Fabrice Zumbrunnen
WebsiteView website
www.aevis.com

Aevis Victoria SA engages in the healthcare, hospitality, lifestyle, and infrastructure sectors in Switzerland. It operates through Hospitals, Hospitality, and Real Estate segments. The company operates private hospitals, hotels, radiology institutes, pharmacy, urology center, health center, day clinics, spas, patient hotels, and golf courses. It also provides health management programs, lifestyle coaching and anti-aging cosmeceuticals under the Nescens brand. In addition, the company offers ambulance, life sciences related services, medical home, physiotherapy, ophthalmology, sports medicine, medical radiation, stem cells, cosmetics, parking, cleaning services, sterilization, and IT related services. Further, it owns real estate properties in the healthcare and hospitality sectors. The company was founded in 2006 and is headquartered in Fribourg, Switzerland. Aevis Victoria SA operates as a subsidiary of M.R.S.I. Medical Research, Services and Investments S.A.

Recent AEVS News & Updates

User avatar
New Narrative • May 13

Aging Population And Integrated Care Model Will Support Future Hospital And Real Estate Earnings

Catalysts About Aevis Victoria Aevis Victoria is an investment company focused on services to people across healthcare, hospitality, and related real estate and ventures. What are the underlying business or industry changes driving this perspective?

Recent updates

No updates

Aevis Victoria SA Competitors

YPSN logo

Ypsomed Holding

Symbol: SWX:YPSN
Market cap: CHF 4.6b
GALE logo

Galenica

Symbol: SWX:GALE
Market cap: CHF 4.1b
MOVE logo

Medacta Group

Symbol: SWX:MOVE
Market cap: CHF 2.2b
View more competitors

Make Better Investing Decisions Anywhere

Scan to download
Open AppStoreOpen Google Play
Chrome Web Store
Level 5, 320 Pitt Street, Sydney
Financial Data provided by S&P Global Market Intelligence LLC, analysis provided by Simply Wall Street Pty Ltd. Copyright © 2026, S&P Global Market Intelligence LLC. All rights reserved.
View Data Sources
Markets
  • US: NYSE & NASDAQ
  • UK: FTSE
  • Australia: ASX
  • India: NIFTY
  • Canada: TSX
  • South Africa: JSE
  • Japan: NIKKEI
  • South Korea: KOSPI
  • Germany: DAX
Investing Ideas
  • Undervalued Companies
  • Dividend Powerhouses
  • Insider Buying
  • Nuclear Energy
  • Autonomous Vehicles
  • Artificial Intelligence
  • Crypto and Blockchain
  • Cybersecurity
  • More ideas
Stock Communities
  • AstraZeneca
  • HSBC Holdings
  • Shell
  • Unilever
  • Diageo
  • Rio Tinto Group
  • RELX
  • BP
  • Barclays
Features & Tools
  • Portfolio Tracker
  • Stock Screener & Alerts
  • Narratives & Fair Values
  • Dividend Calculator
News & Discovery
  • Latest Stock News
  • Global Market Insights
  • The Foxhole
  • Investing Ideas
  • Community Narratives
  • What's New
Simply Wall St
  • Plans & Pricing
  • Advertising
  • About Us
  • Contact Us
  • Careers
  • Help Center
  • Learn Stock Investing
  • Affiliate Program
  • Business & Enterprise
  • Charlie AI
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.
© 2026 Simply Wall Street Pty Ltd, US Design Patent #29/544/281, Community and European Design Registration #2845206
  • Terms and Conditions
  • Privacy Policy
  • AI Terms
  • Financial Services Guide